Zenas BioPharma files Form 3 showing InnoCare Pharma stake of 7 million shares
Reuters2026/09/08 10:51- Zenas BioPharma disclosed a new Form 3 filing showing InnoCare Pharma as a 10% owner.
- InnoCare reported direct ownership of 7 million shares of common stock.
- The filing listed Aug. 26, 2026 as the event date.
- No derivative securities were reported.
Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.
You may also like
XRP Avengers claims holding 10,000 XRP could yield $1 million, community reacts
AI computing power demand ignites nuclear capital enthusiasm: Holtec (HNUC.US) plans IPO to raise 900 million dollars, targeting a 10 billion dollar valuation.
Nuclear supplier Holtec is seeking to raise up to $900 million through a U.S. initial public offering, as companies aim to profit from the growing electricity demand driven by data centers.
Longest in Five Years! US Stock Earnings Upward Revision Trend Hits Record Since 2021, May Signal Another Profitable Earnings Season Ahead
Supported by strong corporate earnings prospects, U.S. stocks are demonstrating considerable resilience and are withstanding the impact of rising inflationary pressures.
Middle East Turmoil, Higher Crude Bills Damp European Bourses Midday
Crypto prices
More
